Effects of omega-3 fatty acids on cytokines and adhesion molecules

Current Atherosclerosis Reports

Volumn 6, Issue 6, 2004, Pages 485-491

  De Caterina, Raffaele ^a   Madonna, Rosalinda ^b   Massaro, Marika ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; CYTOKINE; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; LEUKOTRIENE DERIVATIVE; LINSEED OIL; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RAPESEED OIL; THROMBOXANE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; DIETARY INTAKE; DISEASE COURSE; DOSE RESPONSE; ENDOTHELIUM CELL; GENE EXPRESSION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; REVIEW; RISK REDUCTION; VASCULAR DISEASE;

EID: 9744235770     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-004-0090-x     Document Type: Review

References (42)

1. De Caterina R, Zampolli A: n-3 fatty acids: antiatherosclerotic effects. Lipids 2001, 36:S69-S78.
2. Davilgus M, Stamler J, Orencia A, et al.: Fish consumpion and the 30-year risk of fatal myocardial inarction. N Engl J Med 1997, 336:1046-1053.
3. Albert C, Campos H, Stampfer M, et al.: Blood levels of long-chain n-3 fatty acids and the riesk of sudden death. N Engl J Med 2002, 346:1113-1118.
4. Kris-Etherton P, Harris W, Appel L, for the AHA Nutrition Committee: Omega-3 fatty acids and cardiovascular disease - new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003, 23:151-152.
5. Middaugh J: Cardiovascular death among Alaskan natives 1980-1986. Am J Public Health 1990, 80:282-285.
6. Newman W, Middaugh J, Propst M, Rogers D: Atherosclerosis in Alaskan natives and non-natives. Lancet 1993, 341 1056-1057.
7. Sacks F, Stone P, Gibson C, et al.: Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995, 25:234-237.
8. von Shacky C, Angerer P, Kothny W, et al.: The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130:554-562.
9. Angerer P, Kothny W, Stork S, von Schacky C: Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovasc Res 2002, 54 183-190.
10. Angerer P, von Shacky C: n-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol 2000, 11 57-63.
11. Eritsland J, Arnesen H, Gronseth K, et al.: Effect of supplementation with n-3 fatty acids on grft patency in patients undergoing coronary artery bypass operation. Results from the SHOT study [abstract 351]. Eur Heart J 1994, 15:29.
12. Slack J, Pinkerton C, VanTassel J: Can oral fish oil supplement minimize re-stenosis after percutaneous transluminal angioplasty? [abstract]. J Am Coll Cardiol 1987, 9:64.
13. Dehmer GJ, Popma JJ, van den Berg EK, et al.: Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988, 241:733-740.
14. Grigg L, Kay T, Valentine P, et al.: Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 1989, 13:665-672.
15. Milner M, Gallino R, Leffingwell A, et al.: Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1989, 64:294-299.
16. Reis G, Boucher T, Sipperly M, et al.: Randomised trial of fish oil for prevention of restenosis after coronary angioplasty Lancet 1989, 11:177-181.
17. Nye E, Ilsley C, Ablett M, et al.: Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty Aust NZ J Med 1990, 20:549-552.
18. Bairati I, Roy L, Meyer F: Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation S-I 1992, 85 950-956.
19. Kaul U, Saghvi S, Bahl V, et al.: Fish oil supplements for prevention of restenosis after coronary angioplasty. Int J Cardiol 1992, 35:87-93.
20. Franzen D, Schannwell M, Oette K, Hopp H: A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA. Cathet Cardiovasc Diagn 1993, 28:301-310.
21. Bellamy C, Schofield P, Faragher E, Ramsdale D: Can supplementation with omega-3 polyunsaturated fatty acids reduce coronary angioplasty restenosis rate? Eur Heart J 1992, 3 1626-1631.
22. Leaf A, Jorgensen M, Jacobs A, et al.: Do fish oils prevent restenosis after coronary angioplasty? Circulation S-I 1994, 90:2248-2257.
23. Cairns J, Gill J, Morton B, et al.: for the EMPAR Collaborators: Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation S-I 1996, 94 1553-1560.
24. Maresta A, Balduccelli M, Varani E, et al.: Prevention of post-coronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis Italian Study (ESPRIT). Am Heart J 2002, 143: 1-10.
25. De Caterina R, Gimbrone MA Jr: Leukocyte-endothelial interactions and the pathogenesis of atherosclerosis. In n-3 Fatty Acids - Prevention and Treatment in Vascular Disease. Edited by Kristensen SD, Schmidt EB, De Caterina R, Endres S. London: Springer Verlag; 1995:9-24.
26. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993, 13:197-204.
27. Cybulsky MJ, Iiyama K, Li H, et al.: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001, 107:1255-1262.
28. Libby P: Inflammation in atherosclerosis. Nature 2002, 420:866-874.
29. Libby P: Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003, 91(Suppl):3A-6A.
30. De Caterina R, Zampolli A: From asthma to atherosclerosis - 5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 2004, 350:4-7.
31. De Caterina R, Cybulsky MI, Clinton SK, et al.: The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of pro-atherogenic and pro-inflammatory proteins in human endothelial cells. Arterioscler Thromb 1994, 14:1829-1836.
32. De Caterina R, Cybulsky M, Clinton S, et al.: Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostagl Leukotr Ess Fatty Acids 1995, 52:191-195.
33. Weber C, Erl W, Pietsch A, et al.: Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 1995, 15:622-628.
34. Collins T: Endothelial nuclear factor-kB and the initiation of the atherosclerotic lesion. Lab Invest 1993, 68 499-508.
35. Collins T, Read M, Neish A, et al.: Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokine-inducible enhancers. FASEB J 1995, 9:899-909.
36. Kang JX, Wang J, Wu L, Kang ZB: Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427:504.
37. De Caterina R, Bernini W, Carluccio M, et al.: Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res 1998, 39 1062-1070.
38. Carluccio M, Massaro M, Bonfrate C, et al.: Oleic acid inhibits endothelial activation - a direct vascular antiatherogenic mechanism of a nutritional component in the Mediterranean diet. Arterioscler Thromb Vasc Biol 1999, 19:220-228.
39. De Caterina R, Libby P, Peng HB, et al.: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995, 96:60-68.
40. Massaro M, Basta G, Lazzerini G, et al.: Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis. Thromb Haemost 2002, 88:335-344.
41. Dyerberg J, Bang HO, Stofferson E, et al.: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis Lancet 1978, 2:117-119.
42. Endres S, Ghorbani R, Kelley VE: The effect of dietary supplementation with n-3 polyunsaturated fatty acid on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265-271.